Form 8-K TANDEM DIABETES CARE For: Feb 26
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Tandem Diabetes Care (TNDM) PT Lowered to $35 at Citi
February 27, 2025 5:42 AM ESTCiti analyst Joanna Wuensch lowered the price target on Tandem Diabetes Care (NASDAQ: TNDM) to $35.00 (from $50.00) while maintaining a Buy rating.
The analyst comments "Tandem delivered 4Q24 revenue that was modestly higher than expectations, delivering $252.4M (up 20.6%) ahead of consensuss $249.7M,... More
